As Global Head of Johnson & Johnson Innovation, JLABS, Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage. By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer and health tech, medical device and pharmaceuticals.
Prior to joining JLABS, Melinda was Founder and CEO of Prescience International, an award-winning firm dedicated to accelerating research to the patient.
Melinda is Vice Chair of the California Life Sciences Association (CLSA), a board member of BIO’s Technology Transfer Committee, the Texas Health Catalyst Advisory Panel (The Dell Medical School and the Provost office of the University of Texas at Austin), the University of Toronto & Janssen Neuroscience Catalyst, A*STAR ETPL’s Strategic Advisory Panel.
The Fourth Industrial Revolution Inside Global Giants
Description: These two global companies revamped their approach to innovation, product development, and reoriented themselves towards a digital society. How do they work with the global innovation ecosystem? What are the new opportunities of speed, and the impediments to achieving it? The Fourth Industrial Revolution Inside Global Giants (Transcription by RA Fisher Ink) Kampel: So, over […]
Conferences
Techonomy 18
Techonomy 2018 was a probing, wide-ranging conversation about the tech-inflected issues that affect business and our world. This year’s theme was Harnessing Tech for Responsible Growth, and as always we addressed many of the issues facing leaders today.
